Madrigal Pharmaceuticals receives three new resmetirom patents

Go back to Madrigal Pharmaceuticals receives three new resmetirom patents
(NASDAQ: MDGL) Delayed: 546.66 +12.50 (2.34%)
Previous Close $534.16    52 Week High $18.24 
Open $529.50    52 Week Low $6.60 
Day High $549.97    P/E N/A 
Day Low $526.88    EPS $0.00 
Volume 281,256